Acute COVID-19-associated cardiovascular syndrome: state of the problem and clinical observation

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A review of data on the impact of a new coronavirus infection, COVID-19, on cardiovascular diseases is presented. When treating patients, it is necessary to timely apply additional instrumental research methods, control biomarkers of myocardial damage, and reasonably prescribe medications.

全文:

受限制的访问

作者简介

T. Zanegina

52th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

编辑信件的主要联系方式.
Email: zaneginat@rambler.ru
俄罗斯联邦, Moscow

L. Khachaturyan

52th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: zaneginat@rambler.ru
俄罗斯联邦, Moscow

O. Didenko

52th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: zaneginat@rambler.ru
俄罗斯联邦, Moscow

N. Pakhomova

52th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: zaneginat@rambler.ru
俄罗斯联邦, Moscow

E. Vitrenko

52th Consultative and Diagnostic Center of the Ministry of Defense of the Russian Federation

Email: zaneginat@rambler.ru
俄罗斯联邦, Moscow

参考

  1. Зайцев А.А., Савушкина О.И., Черняк А.В., Кулагина И.Ц., Крюков Е.В. Клинико-функциональная характеристика пациентов, перенесших новую коронавирусную инфекцию COVID-19 // Практич. пульмонол. – 2020. – № 1. – С. 78–81.
  2. Шляхто Е.В., Конради А.О., Арутюнов Г.П. и др. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19 // Рос. кардиол. журн. – Т. 25, № 3. – С. 129–148.
  3. Guo T., Fan Y., Chen M. et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19) // JAMA Cardiol. – 2020. – Vol. 5, N 7. – Р. 811–818. doi: 10.1001/jamacardio.2020.1017
  4. Gurwitz D. Angiotensin receptor blokers as tentative SARS-CoV-2 therapeutics // Drug. Dev. Res. – 2020. – Vol. 81, N 5.– Р. 537–540. doi: 10.1002/ddr.21656
  5. Huang C., Wang Y., Li X. et al. Сlinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. – 2020. – Vol. 395. – P. 497–506. doi: 10.1016/S0140-6736(20)30183-5
  6. Inciardi R. M., Lupi L., Zaccone G. et al. Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19) // JAMA Cardiol. – 2020. – Vol. 5, N 7. – Р. 819–824. doi: 10.1001/jamacardio.2020.1096
  7. Kwong J. C., Schwartz K. L., Campitelli M.A. et al. Acute Myocardial Infarction after Laboratory – Confirmed Influenza Infection // N. Engl. J. Med. – 2018. – Vol. 378, N 4. – P. 345–353. doi: 10.1056/NEJMoa1702090
  8. Li B., Yang J., Zhao F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China // Clin. Res. Cardiol. – 2020. – Vol. 109, N 5. – P. 531–538. DOI: 10. 1007/s00392-020-01626-9
  9. Long B., Brady W. J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19 // Am. J. Emerg. Med. – 2020. – Vol. 38, N 7.– Р. 1504–1507. DOI: 10.1016/j. ajem.2020.04.048
  10. Mehra M. R., Desai S. S., Ruschitzka F., Patel A.N. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis // Lancet. – 2020. – Published Online May 22. DOI: https://doi.org/10.1016/S0140-6736(20) 31180-6
  11. Niu L., An X.-J., Tian J., Wang Y. 124 cases of clinical analysis of children with viral myocarditis // Eur. Rev. Med. Pharmacol. Sci. – 2015. – Vol. 19, N 15. – Р. 2856–2859.
  12. Oudit G.Y., Kassiri Z., Jiang C. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS // Eur. J. Clin. Invest. – 2009. – Vol. 39, N 7. – P. 618–625. doi: 10.1111/j.1365–2362.2009.02153.x
  13. Ruan Q., Yang K., Wang W. et al. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China // Intens. Care Med. – 2020. – Vol. 46. – P. 1294–1297. doi: 10.1007/s00134-020-06028-z
  14. Shi S., Qin M., Shen B. et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China // JAMA Cardiol. – 2020. – Vol. 5. – Р. 802–810. doi: 10.1001/jamacardio.2020.0950
  15. Wang D., Hu B., Hu C. et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China // JAMA. – 2020. – Vol. 323, N 11. – P. 1061–1069. doi: 10.1001/jama.2020.1585
  16. Welt F.G.P., Shah P.B., Aronow H.D. et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI // J. Am. Coll. Cardiol. – 2020. – Vol. 75, N 18. – Р. 2372–2375. doi: 10.1016/j.jacc. 2020.03.021
  17. Yang C., Jin Z. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic – COVID-19 and Cardiovascular Diseases // JAMA Cardiol. – 2020. – Vol. 5, N 7.– Р. 743–744. doi: 10.1001/jamacardio.2020.0934
  18. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. – 2020. – Vol. 395, Iss. 10229. – P. 1054–1062. doi: 10.1016/S0140-6736(20)30566-3

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Zanegina T.A., Khachaturyan L.E., Didenko O.I., Pakhomova N.I., Vitrenko E.S., 2023


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.
##common.cookie##